In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis

Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran

(2016) M Nazeri et al.   Indian Journal of Medical Microbiology

The ABC transporter YejABEF is required for resistance to antimicrobial peptides and the virulence of Brucella melitensis

(2016) Zhen Wang et al.   Scientific Reports

In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

(2015) Anand Deshmukh et al.   BMC MICROBIOLOGY

Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation

(2015) Yue Sun et al.   MEDIATORS OF INFLAMMATION

In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria

(2015) Jafar Amani et al.   PROTEIN AND PEPTIDE LETTERS

The development of antimicrobial peptides as an approach to prevention of antibiotic resistance

(2015) Mehrdad M. Moghaddam et al.   REVIEWS IN MEDICAL MICROBIOLOGY

Combinations of β-Lactam or Aminoglycoside Antibiotics with Plectasin Are Synergistic against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus

(2015) Yanmin Hu et al.   PLoS One

Mechanism of Quinolone Action and Resistance

(2014) Katie J. Aldred et al.   BIOCHEMISTRY

Bacteriostatic Antimicrobial Combination: Antagonistic Interaction between Epsilon-Viniferin and Vancomycin against Methicillin-ResistantStaphylococcus aureus

(2014) Dayang Fredalina Basri et al.   Biomed Research International

Brucellosis in low-income and middle-income countries

(2013) Matthew P. Rubach et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells

(2013) Mehrdad Moosazadeh Moghaddam et al.   WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY

Antimicrobial Susceptibilities of Brucella Isolates from Various Clinical Speciemens

(2012) Yasemin Bayram et al.   International Journal of Medical Sciences

Antimicrobial Peptides for Therapeutic Applications: A Review

(2012) Min-Duk Seo et al.   MOLECULES

In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance

(2012) Mohamed Abdel-Maksoud et al.   Annals of Clinical Microbiology and Antimicrobials

Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli

(2012) M. Moosazadeh Moghaddam et al.   Probiotics and Antimicrobial Proteins

Simultaneous detection and differentiates of Brucella abortus and Brucella melitensis by combinatorial PCR

(2011) Reza Mirnejad et al.   Asian Pacific Journal of Tropical Medicine

Antibacterial Activity and Synergism of the Hybrid Antimicrobial Peptide, CAMA-syn

(2010)   BULLETIN OF THE KOREAN CHEMICAL SOCIETY

Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens

(2009) Sung-Hoon Lee et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Outer membrane permeability and antibiotic resistance

(2008) Anne H. Delcour   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection

(2008) Oscar Cirioni et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY